ArticleMolecular therapy : the journal of the American Society of Gene Therapy2011
AAV9: over the fence and into the woods . . .
Article in Molecular therapy : the journal of the American Society of Gene Therapy, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed.
- First pilot study of intrastromal rAAV-PAX6 gene therapy suggests improved corneal thickness and transcription correction in aniridic mouse.Molecular therapy. Advances · 2026Article
- Multimodal deep learning outperforms clinical and brain region models in predicting stroke-associated pneumonia: an explainable AI study.Frontiers in neurology · 2026Article
- Adeno-Associated Viral Vectors as Versatile Tools for Parkinson's Research, Both for Disease Modeling Purposes and for Therapeutic Uses.International journal of molecular sciences · 2021Review
- MRI-Guided Focused Ultrasound for Targeted Delivery of rAAV to the Brain.Methods in molecular biology (Clifton, N.J.) · 2019Article
- Fiber-modified adenovirus for central nervous system Parkinson's disease gene therapy.Viruses · 2014Article
- Gene therapy for misfolding protein diseases of the central nervous system.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2013Review
- Cerebral infusion of AAV9 vector-encoding non-self proteins can elicit cell-mediated immune responses.Molecular therapy : the journal of the American Society of Gene Therapy · 2013Article
- Targeted delivery of self-complementary adeno-associated virus serotype 9 to the brain, using magnetic resonance imaging-guided focused ultrasound.Human gene therapy · 2012Article
- Gene-based therapy of Parkinson's Disease: Translation from animal model to human clinical trial employing convection enhanced delivery.Annals of neurosciences · 2012Review
- Retrograde gene delivery to hypoglossal motoneurons using adeno-associated virus serotype 9.Human gene therapy methods · 2012Article
- Adeno-associated virus serotype 9 transduction in the central nervous system of nonhuman primates.Human gene therapy · 2012Article
- Gene therapy: light is finally in the tunnel.Protein & cell · 2011Review
- Systemic gene delivery in large species for targeting spinal cord, brain, and peripheral tissues for pediatric disorders.Molecular therapy : the journal of the American Society of Gene Therapy · 2011Article
Corrections and comments
- Comment on
- Comment on
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.